PBM Conflict Of Interest Study May Affect Their Role Under Medicare Rx
This article was originally published in The Pink Sheet Daily
Executive Summary
Congress may revise the role of pharmacy benefit managers under the Medicare drug benefit based on the outcome of a Federal Trade Commission study, Sen. Michael Enzi (R-Wyo.) said